101 related articles for article (PubMed ID: 15155826)
1. Getting past the asterisk: the subunit composition of presynaptic nicotinic receptors that modulate striatal dopamine release.
Luetje CW
Mol Pharmacol; 2004 Jun; 65(6):1333-5. PubMed ID: 15155826
[No Abstract] [Full Text] [Related]
2. Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.
Salminen O; Murphy KL; McIntosh JM; Drago J; Marks MJ; Collins AC; Grady SR
Mol Pharmacol; 2004 Jun; 65(6):1526-35. PubMed ID: 15155845
[TBL] [Abstract][Full Text] [Related]
3. Midbrain muscarinic receptors modulate morphine-induced accumbal and striatal dopamine efflux in the rat.
Miller AD; Forster GL; Yeomans JS; Blaha CD
Neuroscience; 2005; 136(2):531-8. PubMed ID: 16216430
[TBL] [Abstract][Full Text] [Related]
4. Presynaptic nicotinic receptors modulating dopamine release in the rat striatum.
Wonnacott S; Kaiser S; Mogg A; Soliakov L; Jones IW
Eur J Pharmacol; 2000 Mar; 393(1-3):51-8. PubMed ID: 10770997
[TBL] [Abstract][Full Text] [Related]
5. Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and alpha6 and beta3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat.
Visanji NP; Mitchell SN; O'Neill MJ; Duty S
Neuropharmacology; 2006 Jan; 50(1):36-46. PubMed ID: 16153666
[TBL] [Abstract][Full Text] [Related]
6. Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: implications for drug development.
Janhunen S; Ahtee L
Neurosci Biobehav Rev; 2007; 31(3):287-314. PubMed ID: 17141870
[TBL] [Abstract][Full Text] [Related]
7. Complementary motivational roles of nigroaccumbens and nigrostriatal dopaminergic pathways.
Albin RL
Mov Disord; 2019 Jan; 34(1):45. PubMed ID: 30653732
[No Abstract] [Full Text] [Related]
8. Modulation of dopamine release by striatal 5-HT2C receptors.
Alex KD; Yavanian GJ; McFarlane HG; Pluto CP; Pehek EA
Synapse; 2005 Mar; 55(4):242-51. PubMed ID: 15668911
[TBL] [Abstract][Full Text] [Related]
9. Subcellular distribution and plasticity of neurokinin-1 receptors in the rat substantia nigra and ventral tegmental area.
Lessard A; Pickel VM
Neuroscience; 2005; 135(4):1309-23. PubMed ID: 16165296
[TBL] [Abstract][Full Text] [Related]
10. Partial depletion of dopamine in substantia nigra impairs motor performance without altering striatal dopamine neurotransmission.
Andersson DR; Nissbrandt H; Bergquist F
Eur J Neurosci; 2006 Jul; 24(2):617-24. PubMed ID: 16903863
[TBL] [Abstract][Full Text] [Related]
11. Glial bFGF and S100 immunoreactivities increase in ascending dopamine pathways following striatal 6-OHDA-induced partial lesion of the nigrostriatal system: a sterological analysis.
Gomide V; Chadi G
Int J Neurosci; 2005 Apr; 115(4):537-55. PubMed ID: 15809219
[TBL] [Abstract][Full Text] [Related]
12. Involvement of nicotinic and muscarinic acetylcholine receptors on striatal HgCl2-induced dopamine release in freely moving rats.
Vidal L; Durán R; Faro LR; Alfonso M
Toxicol Lett; 2008 May; 178(3):181-4. PubMed ID: 18439770
[TBL] [Abstract][Full Text] [Related]
13. Midbrain muscarinic receptor mechanisms underlying regulation of mesoaccumbens and nigrostriatal dopaminergic transmission in the rat.
Miller AD; Blaha CD
Eur J Neurosci; 2005 Apr; 21(7):1837-46. PubMed ID: 15869479
[TBL] [Abstract][Full Text] [Related]
14. Nicotinic acetylcholine receptors in the anterior, but not posterior, ventral tegmental area mediate ethanol-induced elevation of accumbal dopamine levels.
Ericson M; Löf E; Stomberg R; Chau P; Söderpalm B
J Pharmacol Exp Ther; 2008 Jul; 326(1):76-82. PubMed ID: 18369179
[TBL] [Abstract][Full Text] [Related]
15. Organization of ventral tegmental area projections to the ventral tegmental area-nigral complex in the rat.
Ferreira JG; Del-Fava F; Hasue RH; Shammah-Lagnado SJ
Neuroscience; 2008 Apr; 153(1):196-213. PubMed ID: 18358616
[TBL] [Abstract][Full Text] [Related]
16. Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice.
Le Foll B; Diaz J; Sokoloff P
Life Sci; 2005 Jan; 76(11):1281-96. PubMed ID: 15642598
[TBL] [Abstract][Full Text] [Related]
17. Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease.
Kas A; Bottlaender M; Gallezot JD; Vidailhet M; Villafane G; Grégoire MC; Coulon C; Valette H; Dollé F; Ribeiro MJ; Hantraye P; Remy P
J Cereb Blood Flow Metab; 2009 Sep; 29(9):1601-8. PubMed ID: 19491921
[TBL] [Abstract][Full Text] [Related]
18. Correlation between dopaminergic neurons, acetylcholinesterase and nicotinic acetylcholine receptors containing the alpha3- or alpha5-subunit in the rat substantia nigra.
Emmett SR; Greenfield SA
J Chem Neuroanat; 2005 Jul; 30(1):34-44. PubMed ID: 15975762
[TBL] [Abstract][Full Text] [Related]
19. Neurochemical characterization of the release and uptake of dopamine in ventral tegmental area and serotonin in substantia nigra of the mouse.
John CE; Budygin EA; Mateo Y; Jones SR
J Neurochem; 2006 Jan; 96(1):267-82. PubMed ID: 16300629
[TBL] [Abstract][Full Text] [Related]
20. Unconventional effects of estrogen uncovered.
Dluzen DE
Trends Pharmacol Sci; 2005 Oct; 26(10):485-7. PubMed ID: 16122814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
